Hi Kami, All things pointing toward a positive outcome re: FDA review . Mithra Pharma have a strong buy recommendation from several different sources,the one from "simply wall st" is really interesting,they're nudging a billion EURO market cap or thereabouts. Gaining an exclusive on the E4 product till 2036 in europe,with similar applications in the US right now.(Richards didn't think it was important enough to warrant a market release,go figure ) I think MYX are only going to keep gaining traction the closer we get to April 2021(shorts down around 2.6 % last look). The ducks are really starting to line up and i cannot see Mithra waiting to long to pounce once they get their 10% stake after approval.They seem to have the balance sheet for it.Take MYX out,package up all the rubbish and offload it,they'll have a footprint in the United States and a second production facility..... and finally show the door to the fools whom have presided over so much carnage with their decision making and dont have the balls to fall on they're swords!!!!
MYX Price at posting:
37.0¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)